It’s not exactly news that Ozempic, Wegovy and other GLP-1 drugs are catching on, with some surveys showing nearly 12% of Americans have used the

UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

(Reuters) -The U.S. Food and Drug Administration sent an import alert on Friday to help stop illegal imports of GLP-1 drug ingredients entering the…

Post Content

Biomedicines, Vol. 13, Pages 2174: Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs Biomedicines doi: 10.3390/biomedicines13092174 Authors:

The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said

Find out more about recent trends in China’s infant formula sales, eye health supplement ingredients, and biotics for GLP-1 in this round-up.

Explore how GLP-1 therapies, beyond weight loss and diabetes care, may influence male fertility by improving hormonal balance, metabolism, and reproductive health outcomes.

(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse

CVS Health Corp.’s pharmacy benefit manager Caremark RX LLC is facing a lawsuit challenging its decision to stop coverage of weight loss drug Zepbound in

SupplySide Global 2025 to Spotlight Transformative Industry Trends in Artificial Intelligence, Natural Colors, GLP-1 Innovations and Global Trade Impacts  The Globe and Mail

When I turned 50, I weighed 265 pounds. Over the next 12 years, through walking, yoga, and strength training, I lost 60 pounds and kept

An increasing proportion of bariatric surgery patients are taking GLP-1 weight-loss drugs in the years following their surgery. Medscape Medical News

MeAgain is designed specifically for people on GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, Zepbound®, generics and compounds. MeAgain helps you build and stay on track

Background: Glucagon-like peptide-1 (GLP-1) medications, recently introduced in the United States for treating type 2 diabetes and obesity, have sparked interest and discussion on social

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. Her

A month has gone by since the last earnings report for Inspire Medical Systems (INSP). Shares have added about 7.5% in that time frame, outperforming

WEDNESDAY, Sept. 3, 2025 — Fourteen percent of individuals initiate glucagon-like peptide 1 receptor agonists (GLP-1 RAs) after bariatric surgery, according to a study published

The study showed clinical benefits for semaglutide-based products used strictly in obesity care, but the model projects added net costs for their use in weight

This systematic review and meta-analysis evaluates the risk of suicidality and self-harm in randomized, placebo-controlled trials of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in

In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines

Experts see a place for pill formulations of GLP-1s as treatment for patients to switch to after reaching a target weight or blood sugar level

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions itself as a consumer-first health and wellness platform, designed to transform the

Health Weight loss drugs protect heart patients, study suggests 40% lower risk of hospitalization or death Mass General Brigham Communications September 2, 2025 3 min

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published

TUESDAY, Sept. 2, 2025 — Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduction in the risk for developing uveitis, according to

For patients with type 2 diabetes (T2D) and obesity, glucagon-like peptide-1 (GLP-1) drugs may offer neuroprotective and cerebrovascular benefits in addition to glycemic control, a

This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.

Eli Lilly is on track to release orforglipron next year, which has showed an average of 12 percent weight loss.

Glucagon-like peptide 1 receptor (GLP-1R) agonists exhibit anti-inflammatory actions, yet the importance of direct immune cell GLP-1R signaling remains uncertain. Although T cells respond to

Eli Lilly and Company LLY has gained tremendous market value in the past 2-3 years due to the success of its popular GLP-1 drugs, Mounjaro

Endocrine cells are dedicated to the production and processing of hormones, from peptides to small molecules, to regulate key physiological processes, including glucose homeostasis and

GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and

From GPS to GLP-1 drugs, game-changing ideas often start with federal research dollars funding wacky experiments. Slashing it risks the trillion-dollar industries of tomorrow.

As the oral GLP-1 race intensifies, Eli Lilly has slimmed back the number of phase 2 trials it is conducting for one of its contenders.

Novo Shares Gain As Wegovy Shows Big Edge Over Lilly’s Tirzepatide In Heart Study   Novo Nordisk shares rose in Copenhagen trading on Monday after the